Naohiko Murata   Yoshihito Kogure   Masashi Kondo   Chiyoe Kitagawa   Hideo Saka   
The Kurume medical journal 2021年8月
Although concurrent chemoradiotherapy is the standard therapy for unresectable stage III non-small cell lung cancer (NSCLC), no optimal concurrent chemoradiotherapy regimen has been identified in non-squamous NSCLC. We conducted an open-label, mul...